Asian Phytoceuticals PCL (BKK:APCO)
Thailand · Delayed Price · Currency is THB 2.540
0.00 (0.00%)
Sep 11, 2026, 4:36 PM ICT
Asian Phytoceuticals PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,524 | 1,716 | 2,952 | 3,120 | 3,000 | 3,810 | |
Market Cap Growth | -22.09% | -41.87% | -5.38% | 4.00% | -21.26% | 68.88% |
Enterprise Value | 1,197 | 1,380 | 2,658 | 2,903 | 2,833 | 3,711 |
Last Close Price | 2.54 | 2.76 | 4.62 | 4.71 | 4.39 | 5.44 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.28 | 30.97 | 53.96 | 29.03 | 37.08 | 55.46 |
Forward PE | - | 25.33 | 25.33 | 25.33 | 25.33 | 25.33 |
PS Ratio | 7.75 | 8.57 | 14.00 | 10.66 | 11.98 | 17.06 |
PB Ratio | 2.84 | 3.06 | 5.27 | 5.10 | 4.91 | 6.40 |
P/TBV Ratio | 2.86 | 3.09 | 5.31 | 5.12 | 4.94 | 6.41 |
P/FCF Ratio | 27.80 | 33.37 | 83.49 | 25.84 | 30.04 | 45.78 |
P/OCF Ratio | 26.78 | 32.86 | 78.38 | 25.14 | 29.95 | 45.14 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.08 | 6.90 | 12.61 | 9.92 | 11.31 | 16.61 |
EV/EBITDA Ratio | 15.41 | 22.58 | 44.84 | 23.47 | 29.87 | 45.55 |
EV/EBIT Ratio | 20.46 | 24.67 | 50.06 | 24.84 | 32.18 | 50.27 |
EV/FCF Ratio | 21.83 | 26.84 | 75.19 | 24.05 | 28.37 | 44.59 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.04 | 0.06 | 0.02 | 0.06 |
Debt / EBITDA Ratio | 0.08 | 0.18 | 0.33 | 0.26 | 0.12 | 0.34 |
Debt / FCF Ratio | 0.11 | 0.27 | 0.68 | 0.30 | 0.14 | 0.41 |
Net Debt / Equity Ratio | -0.62 | -0.62 | -0.58 | -0.35 | -0.27 | -0.22 |
Net Debt / EBITDA Ratio | -5.37 | -5.66 | -5.52 | -1.74 | -1.74 | -1.63 |
Net Debt / FCF Ratio | -6.05 | -6.73 | -9.26 | -1.78 | -1.66 | -1.59 |
Asset Turnover | 0.33 | 0.32 | 0.31 | 0.42 | 0.37 | 0.32 |
Inventory Turnover | 0.43 | 0.49 | 0.81 | 1.18 | 0.85 | 0.76 |
Quick Ratio | 11.17 | 9.01 | 9.24 | 5.53 | 4.07 | 3.56 |
Current Ratio | 13.64 | 10.85 | 10.75 | 6.51 | 5.27 | 4.84 |
Return on Equity (ROE) | 11.14% | 10.11% | 9.52% | 17.78% | 13.47% | 11.54% |
Return on Assets (ROA) | 5.96% | 5.54% | 4.95% | 10.55% | 8.09% | 6.70% |
Return on Invested Capital (ROIC) | 22.61% | 20.35% | 13.85% | 22.67% | 15.68% | 12.68% |
Return on Capital Employed (ROCE) | 10.10% | 9.50% | 8.90% | 17.80% | 13.90% | 11.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.79% | 3.23% | 1.85% | 3.45% | 2.70% | 1.80% |
FCF Yield | 3.60% | 3.00% | 1.20% | 3.87% | 3.33% | 2.18% |
Dividend Yield | 3.55% | 3.29% | 1.99% | 3.82% | 3.53% | 2.27% |
Payout Ratio | 94.45% | 99.55% | 197.27% | 86.46% | 91.44% | 104.73% |
Buyback Yield / Dilution | 7.48% | -1.28% | -1.23% | -0.11% | 0.03% | 0.02% |
Total Shareholder Return | 11.03% | 2.01% | 0.76% | 3.71% | 3.56% | 2.29% |